Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Simponi
Simponi
J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit
Fierce Pharma
Wed, 02/19/20 - 11:40 pm
JNJ
Remicade
Simponi
kickbacks
whistleblower lawsuits
J&J discloses DOJ investigations into marketing, advisory practices
BioPharma Dive
Thu, 05/11/17 - 11:43 am
JNJ
DOJ
drug marketing
Remicade
Olysio
Simponi
Stelara
U.S. prosecutors zero in on J&J marketing, targeting top immunology, hep C meds
Fierce Pharma
Tue, 05/9/17 - 10:43 pm
JNJ
drug manufacturing
immunology
hepatitis C
Remicade
Simponi
Stelara
Olysio
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
Johnson & Johnson Continues To Ride The Success Of Its Immunology And Oncology Drugs
Seeking Alpha
Fri, 10/18/13 - 10:07 am
JNJ
Remicade
Simponi
Stelara
Invokana
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
rheumatoid arthritis
Humira
AbbVie
Enbrel
Amgen
Remicade
Janssen
Celebrex
Pfizer
Bristol-Myers Squibb
Orencia
Cimza
UCB
Simponi
JNJ
Arthrotec
Vimovo
AstraZeneca
Kineret
J&J Wins Expanded Approval of Simponi for Bowel Disease
Bloomberg
Wed, 05/15/13 - 05:15 pm
Simponi
JNJ
FDA
inflammatory bowel disease
Johnson & Johnson Gets CRL on Simponi
Yahoo/Zacks.com
Wed, 09/14/11 - 10:21 am
JNJ
Simponi
Merck
psoriatic arthritis
J&J’s Simponi Fails to Receive U.S. FDA Clearance for Wider Use
Bloomberg
Sat, 09/10/11 - 10:36 am
JNJ
Simponi
psoriatic arthritis
arthritis
Johnson & Johnson’s Simponi Rejected by FDA for Expanded Use
Bloomberg
Sat, 07/23/11 - 04:37 pm
JNJ
Simponi
rheumatoid arthritis
Dark Clouds Lift Over Pharma Dispute
Motley Fool
Sat, 04/16/11 - 01:27 pm
Merck
Schering Plough
JNJ
Remicade
Simponi
Merck, J&J’s Simponi Recommended in U.K. for Psoriatic Arthritis
Bloomberg
Thu, 03/17/11 - 10:36 am
Merck
Simponi
JNJ
UK
psoriatic arthritis
Are Merck And J&J Fighting Over A Shrinking Pie?
Pharmalot
Thu, 01/27/11 - 11:29 am
Merck
JNJ
Simponi
rheumatoid arthritis
Remicade
Centocor asks FDA to expand use of Simponi
Yahoo/AP
Thu, 11/11/10 - 10:55 am
Janssen Biotech
FDA
arthritis
Simponi
JNJ
Merck And Johnson & Johnson Arbitration Is Delayed
Pharmalot
Thu, 10/14/10 - 11:10 am
JNJ
Merck
arbitration
Remicade
Simponi
Centocor seeks expansion of Simponi use
Bizjournals.com
Mon, 09/27/10 - 12:19 pm
Janssen Biotech
Simponi
rheumatoid arthritis
Merck Plays Down J&J Arbitration but Risk Remains
Seeking Alpha
Wed, 08/4/10 - 07:44 am
Merck
JNJ
Simponi
Remicade
J&J's Dilemma: Marketing New Drugs Without Cannibalizing Its Lead Product
BNET Pharma
Tue, 02/23/10 - 02:06 pm
JNJ
Remicade
Simponi
Encouraging Data on J&J's Simponi
Yahoo/Zacks.com
Mon, 11/23/09 - 10:10 am
Simponi
rheumatoid arthritis
JNJ
Centocor Ortho Biotech, Schering-Plough get European approval for Simponi
Pharmabiz
Thu, 10/8/09 - 11:33 am
Janssen Biotech
Ortho Biotech
Schering Plough
Simponi
Pages
1
2
next ›
last »